BAYRY
Price
$7.67
Change
-$0.11 (-1.41%)
Updated
Jul 3 closing price
Capitalization
57.55B
32 days until earnings call
CSPCY
Price
$4.12
Change
+$0.18 (+4.57%)
Updated
Jul 3 closing price
Capitalization
9.91B
Interact to see
Advertisement

BAYRY vs CSPCY

Header iconBAYRY vs CSPCY Comparison
Open Charts BAYRY vs CSPCYBanner chart's image
Bayer A.G
Price$7.67
Change-$0.11 (-1.41%)
Volume$369.18K
Capitalization57.55B
CSPC Pharmaceuticals Group
Price$4.12
Change+$0.18 (+4.57%)
Volume$21.94K
Capitalization9.91B
BAYRY vs CSPCY Comparison Chart in %
Loading...
BAYRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CSPCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BAYRY vs. CSPCY commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAYRY is a Hold and CSPCY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (BAYRY: $7.67 vs. CSPCY: $4.12)
Brand notoriety: BAYRY and CSPCY are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: BAYRY: 51% vs. CSPCY: 739%
Market capitalization -- BAYRY: $57.55B vs. CSPCY: $9.91B
BAYRY [@Pharmaceuticals: Major] is valued at $57.55B. CSPCY’s [@Pharmaceuticals: Major] market capitalization is $9.91B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BAYRY’s FA Score shows that 0 FA rating(s) are green whileCSPCY’s FA Score has 2 green FA rating(s).

  • BAYRY’s FA Score: 0 green, 5 red.
  • CSPCY’s FA Score: 2 green, 3 red.
According to our system of comparison, CSPCY is a better buy in the long-term than BAYRY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BAYRY’s TA Score shows that 4 TA indicator(s) are bullish while CSPCY’s TA Score has 3 bullish TA indicator(s).

  • BAYRY’s TA Score: 4 bullish, 5 bearish.
  • CSPCY’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, BAYRY is a better buy in the short-term than CSPCY.

Price Growth

BAYRY (@Pharmaceuticals: Major) experienced а 0.00% price change this week, while CSPCY (@Pharmaceuticals: Major) price change was +2.50% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.19%. For the same industry, the average monthly price growth was +2.56%, and the average quarterly price growth was +9.33%.

Reported Earning Dates

BAYRY is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+1.19% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BAYRY($57.5B) has a higher market cap than CSPCY($9.91B). BAYRY has higher P/E ratio than CSPCY: BAYRY (17.04) vs CSPCY (11.34). CSPCY YTD gains are higher at: 76.977 vs. BAYRY (57.921). BAYRY has higher annual earnings (EBITDA): 12.1B vs. CSPCY (7.63B). BAYRY has higher revenues than CSPCY: BAYRY (50.5B) vs CSPCY (31.1B).
BAYRYCSPCYBAYRY / CSPCY
Capitalization57.5B9.91B580%
EBITDA12.1B7.63B159%
Gain YTD57.92176.97775%
P/E Ratio17.0411.34150%
Revenue50.5B31.1B162%
Total Cash7.98BN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
BAYRY vs CSPCY: Fundamental Ratings
BAYRY
CSPCY
OUTLOOK RATING
1..100
7950
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
21
Undervalued
PROFIT vs RISK RATING
1..100
10082
SMR RATING
1..100
9342
PRICE GROWTH RATING
1..100
4037
P/E GROWTH RATING
1..100
8913
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CSPCY's Valuation (21) in the null industry is somewhat better than the same rating for BAYRY (70). This means that CSPCY’s stock grew somewhat faster than BAYRY’s over the last 12 months.

CSPCY's Profit vs Risk Rating (82) in the null industry is in the same range as BAYRY (100). This means that CSPCY’s stock grew similarly to BAYRY’s over the last 12 months.

CSPCY's SMR Rating (42) in the null industry is somewhat better than the same rating for BAYRY (93). This means that CSPCY’s stock grew somewhat faster than BAYRY’s over the last 12 months.

CSPCY's Price Growth Rating (37) in the null industry is in the same range as BAYRY (40). This means that CSPCY’s stock grew similarly to BAYRY’s over the last 12 months.

CSPCY's P/E Growth Rating (13) in the null industry is significantly better than the same rating for BAYRY (89). This means that CSPCY’s stock grew significantly faster than BAYRY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BAYRYCSPCY
RSI
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
59%
Bullish Trend 3 days ago
65%
Momentum
ODDS (%)
Bearish Trend 3 days ago
65%
Bearish Trend 3 days ago
78%
MACD
ODDS (%)
Bearish Trend 3 days ago
67%
Bearish Trend 3 days ago
63%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
62%
Bullish Trend 3 days ago
68%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
62%
Bullish Trend 3 days ago
67%
Advances
ODDS (%)
Bullish Trend 9 days ago
59%
Bullish Trend 3 days ago
68%
Declines
ODDS (%)
Bearish Trend 3 days ago
71%
Bearish Trend 9 days ago
74%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
67%
Bearish Trend 3 days ago
74%
Aroon
ODDS (%)
Bullish Trend 3 days ago
55%
Bullish Trend 3 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
BAYRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CSPCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VG15.560.10
+0.65%
Venture Global Inc
KW7.270.04
+0.55%
Kennedy-Wilson Holdings
CLNN3.90N/A
N/A
Clene Inc.
LEGT10.67N/A
N/A
Legato Merger Corp
SCCO105.86-0.23
-0.22%
Southern Copper Corp

BAYRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, BAYRY has been closely correlated with BAYZF. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if BAYRY jumps, then BAYZF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BAYRY
1D Price
Change %
BAYRY100%
-1.16%
BAYZF - BAYRY
88%
Closely correlated
-0.90%
OPHLY - BAYRY
23%
Poorly correlated
-0.85%
AZNCF - BAYRY
20%
Poorly correlated
-2.22%
CSPCY - BAYRY
20%
Poorly correlated
+4.50%
ALPMY - BAYRY
13%
Poorly correlated
-0.52%
More

CSPCY and

Correlation & Price change

A.I.dvisor tells us that CSPCY and CHJTF have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CSPCY and CHJTF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSPCY
1D Price
Change %
CSPCY100%
+4.50%
CHJTF - CSPCY
23%
Poorly correlated
N/A
BAYRY - CSPCY
20%
Poorly correlated
-1.16%
OPHLY - CSPCY
20%
Poorly correlated
-0.85%
DSNKY - CSPCY
16%
Poorly correlated
-2.41%
BAYZF - CSPCY
13%
Poorly correlated
-0.90%
More